Stephen Lemieux - Jul 20, 2023 Form 4/A - Amendment Insider Report for Edesa Biotech, Inc. (EDSA)

Role: Chief Financial Officer
Signature: /s/ Stephen Lemieux
Stock symbol: EDSA
Transactions as of: Jul 20, 2023
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 7/24/2023, 04:45 PM
Date Of Original Report: Jul 21, 2023
Previous filing: Jul 17, 2023
Next filing: Aug 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EDSA	Share Option (right to buy)	Award	$0	+75K		$0.00	75K	Jul 20, 2023	Common Shares	75K	$0.83	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option vests monthly in equal proportions over 36 months beginning on the date of grant.

Remarks:

This amendment on Form 4/A is being filed to amend the Form 4 filed on July 21, 2023, solely to correct an administrative error in the expiration date of the Share Option previously reported in Column 6 of Table II.